Oncimmune provides a trading update for the 12 months ended 31 May 2021 (``FY21``)
![Oncimmune 300x300](https://ipfpartners.com/wp-content/uploads/2019/10/Oncimmune-300x300.jpg)
Oncimmune Holdings plc, the leading global immunodiagnostics group, today provides a trading update for the 12 months ended 31 May 2021 (“FY21”).
Oncimmune Holdings plc, the leading global immunodiagnostics group, today provides a trading update for the 12 months ended 31 May 2021 (“FY21”).